Cardiovascular health and diabetes

Module 2: Cardiovascular risk and glycaemic control

Please log in to access the chapters in this module.
CME Credits: 1
Module duration: 1 hour
Launch date: Winter 2019 (version 1)
Updated: Summer 2022 (version 2)
Expiry date: March 2027
Audience: Cardiologists (Subspeciality), Diabetes and Metabolism Specialists (Basic), Endocrinologists (Basic), General Physicians (Subspeciality)

Epidemiologically, fluctuations in glycaemic control and chronic hyperglycemia are recognised as risk factors for cardiovascular disease in people with diabetes. This module examines the controversies from a number of different trials that have been conducted to determine the relationship between glucose control and cardiovascular outcomes.

Learning Outcomes

By the end of this module, you will be able to:

Explain the relationship between glycaemic control and cardiovascular outcomes, and the importance of reducing cardiovascular risk in people with diabetes

Interpret the microvascular and macrovascular outcomes from the ACCORD, ADVANCE, DCCT, UKPDS and VADT studies

Develop management plans for people with diabetes to identify and, where possible, reduce cardiovascular risk


This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.


Contributors

Professor
Miles Fisher
Author
Professor
John Wilding
Expert Reviewer
Assessment Setter